Cargando…
Leukocytoclastic vasculitis and COVID-19 vaccination
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424517/ https://www.ncbi.nlm.nih.gov/pubmed/36162200 http://dx.doi.org/10.1016/j.semerg.2022.101829 |
| _version_ | 1784778239281987584 |
|---|---|
| author | Sookaromdee, P. Wiwanitkit, V. |
| author_facet | Sookaromdee, P. Wiwanitkit, V. |
| author_sort | Sookaromdee, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9424517 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94245172022-08-30 Leukocytoclastic vasculitis and COVID-19 vaccination Sookaromdee, P. Wiwanitkit, V. Semergen Letter to the Editor Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. 2022 2022-08-30 /pmc/articles/PMC9424517/ /pubmed/36162200 http://dx.doi.org/10.1016/j.semerg.2022.101829 Text en © 2022 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Sookaromdee, P. Wiwanitkit, V. Leukocytoclastic vasculitis and COVID-19 vaccination |
| title | Leukocytoclastic vasculitis and COVID-19 vaccination |
| title_full | Leukocytoclastic vasculitis and COVID-19 vaccination |
| title_fullStr | Leukocytoclastic vasculitis and COVID-19 vaccination |
| title_full_unstemmed | Leukocytoclastic vasculitis and COVID-19 vaccination |
| title_short | Leukocytoclastic vasculitis and COVID-19 vaccination |
| title_sort | leukocytoclastic vasculitis and covid-19 vaccination |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424517/ https://www.ncbi.nlm.nih.gov/pubmed/36162200 http://dx.doi.org/10.1016/j.semerg.2022.101829 |
| work_keys_str_mv | AT sookaromdeep leukocytoclasticvasculitisandcovid19vaccination AT wiwanitkitv leukocytoclasticvasculitisandcovid19vaccination |